Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$2.72
-2.2%
$7.99
$2.51
$39.95
$2.08M0.8865,769 shs109,845 shs
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$102.22
-0.1%
$94.12
$61.88
$103.41
$72.14B1.124.34 million shs4.10 million shs
FAP
abrdn Asia-Pacific Income Fund VCC
C$2.91
-0.3%
C$2.91
C$2.67
C$3.04
C$107.28M0.5459,148 shs3,400 shs
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
C$124.95
+1.2%
C$120.52
C$95.51
C$130.16
C$300.67M0.271,920 shs375 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-2.16%-6.85%-70.11%-70.24%-91.39%
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
-0.08%+0.83%+10.25%+19.00%+65.67%
FAP
abrdn Asia-Pacific Income Fund VCC
-0.34%0.00%+0.69%-0.34%+8.99%
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
+1.18%-3.51%+3.31%+18.27%+26.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
1.1479 of 5 stars
3.50.00.00.01.10.00.0
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
4.8315 of 5 stars
2.34.04.22.13.62.53.1
FAP
abrdn Asia-Pacific Income Fund VCC
N/AN/AN/AN/AN/AN/AN/AN/A
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
2.52 of 5 stars
2.50.02.50.00.63.31.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
3.00
Buy$275.0010,010.29% Upside
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
2.57
Moderate Buy$94.38-7.67% Downside
FAP
abrdn Asia-Pacific Income Fund VCC
0.00
N/AN/AN/A
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
3.00
BuyC$147.9118.38% Upside

Current Analyst Ratings Breakdown

Latest FAP, BK, AIM, and OLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$96.00 ➝ $100.00
7/16/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$97.00 ➝ $100.00
7/16/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$105.00 ➝ $113.00
7/16/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$95.00 ➝ $101.00
7/2/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$88.00 ➝ $90.00
6/3/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$94.00 ➝ $95.00
5/28/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$87.00 ➝ $97.00
5/21/2025
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
Fundamental Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuyC$147.91
(Data available from 8/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$146K14.23N/AN/A$0.20 per share13.60
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$39.91B1.81$8.94 per share11.43$55.44 per share1.84
FAP
abrdn Asia-Pacific Income Fund VCC
C$14.12M7.60C$0.44 per share6.60C$2.92 per share1.00
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
C$102.64M2.93C$10.72 per share11.66C$16.72 per share7.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$24.00N/AN/AN/A-12,594.21%-421.73%-147.54%N/A
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$4.53B$6.5515.6113.050.9912.27%13.46%1.16%10/10/2025 (Estimated)
FAP
abrdn Asia-Pacific Income Fund VCC
C$11.23MC$0.319.52N/A79.52%10.17%2.92%N/A
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
C$24.45MC$10.1612.30N/A23.82%64.95%35.88%N/A

Latest FAP, BK, AIM, and OLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/15/2025Q2 2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$1.73$1.94+$0.21$1.93$4.80 billion$4.77 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$2.122.07%N/A32.37%14 Years
FAP
abrdn Asia-Pacific Income Fund VCC
C$0.217.22%N/A68.71%N/A
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
C$7.205.76%N/A70.86%N/A

Latest FAP, BK, AIM, and OLY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/15/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
quarterly$0.532.22%7/25/20257/25/20258/7/2025
7/22/2025
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
MonthlyC$0.605.95%7/22/20257/31/20257/31/2025
6/19/2025
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
MonthlyC$0.606.28%6/19/20256/30/20256/30/2025
5/21/2025
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
MonthlyC$0.606.99%5/21/20255/30/20255/30/2025
6/10/2025
FAP
abrdn Asia-Pacific Income Fund VCC
jun 25C$0.026/23/20251/1/2000
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.05
0.75
0.75
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
0.86
0.72
0.69
FAP
abrdn Asia-Pacific Income Fund VCC
44.38
2.85
0.30
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
6.00
3.32
1.59
CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
20764,00068.74 millionNot Optionable
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
51,800705.24 million704.25 millionOptionable
FAP
abrdn Asia-Pacific Income Fund VCC
N/A36.86 millionN/ANot Optionable
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
3252.41 millionN/ANot Optionable

Recent News About These Companies

Olympia Financial Group Declares August Dividend
TSX Dividend Stocks To Consider In July 2025
Olympia Financial Group Inc. declares $0.60 dividend
Olympia Financial Group Inc. Announces July Dividend
3 Top TSX Dividend Stocks For Your Portfolio
Olympia Financial Group Inc. Announces June Dividend
Top Dividend Stocks On TSX For Reliable Income

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AIM ImmunoTech stock logo

AIM ImmunoTech NYSE:AIM

$2.72 -0.06 (-2.16%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$2.69 -0.03 (-0.96%)
As of 06:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Bank of New York Mellon stock logo

Bank of New York Mellon NYSE:BK

$102.22 -0.07 (-0.07%)
Closing price 08/7/2025 03:59 PM Eastern
Extended Trading
$101.52 -0.70 (-0.69%)
As of 05:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally. The company operates through Securities Services, Market and Wealth Services, Investment and Wealth Management, and other segments. The Securities Services segment offers custody, trust and depositary, accounting, exchange-traded funds, middle-office solutions, transfer agency, services for private equity and real estate funds, foreign exchange, securities lending, liquidity/lending services, and data analytics. This segment also provides trustee, paying agency, fiduciary, escrow and other financial, issuer, and support services for brokers and investors. The Market and Wealth Services segment offers clearing and custody, investment, wealth and retirement solutions, technology and enterprise data management, trading, and prime brokerage services. This segment also provides integrated cash management solutions, including payments, foreign exchange, liquidity management, receivables processing and payables management, and trade finance and processing services. The Investment and Wealth Management segment offers investment management strategies and distribution of investment products, investment management, custody, wealth and estate planning, private banking, investment, and information management services. The Other segment engages in the provision of leasing, corporate treasury, derivative and other trading, corporate and bank-owned life insurance, renewable energy investment, and business exit services. It serves central banks and sovereigns, financial institutions, asset managers, insurance companies, corporations, local authorities and high net-worth individuals, and family offices. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.

abrdn Asia-Pacific Income Fund VCC TSE:FAP

C$2.91 -0.01 (-0.34%)
As of 08/7/2025 03:46 PM Eastern

The investment objective of the Company is to obtain current income and achieve incidental capital appreciation from investment in long-term securities. The Company seeks to obtain these objectives primarily from investment in long-term debt securities. The Company may invest up to 100 percent of its total assets in Asia-Pacific debt securities.

Olympia Financial Group stock logo

Olympia Financial Group TSE:OLY

C$124.95 +1.46 (+1.18%)
As of 08/7/2025 03:09 PM Eastern

Olympia Financial Group Inc is engaged in providing financial services. The company's operating segments are Private Health Services Plan division which markets, sells and administers health and dental benefits to business owners; Investment Account Services division specializes in registered account administration; The Currency and Global Payments division provides corporations and private clients a personalized service for buying and selling foreign currencies; The Exempt Edge division is focused on Onboarding fees; The Corporate and Shareholder Services division, which acts as a cost centre and the Corporate Division.